Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)
- John E. Levine
- , Bruce R. Blazar
- , Todd DeFor
- , James L.M. Ferrara
- , Daniel J. Weisdorf
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations